Business Description
Tauns Laboratories Inc
ISIN : JP3452250008
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 0.76 | |||||
Debt-to-EBITDA | 1.22 | |||||
Interest Coverage | 227.76 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 64.57 | |||||
9-Day RSI | 64.42 | |||||
14-Day RSI | 62.93 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.45 | |||||
Quick Ratio | 0.75 | |||||
Cash Ratio | 0.19 | |||||
Days Inventory | 258.68 | |||||
Days Sales Outstanding | 46.5 | |||||
Days Payable | 71.45 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.02 | |||||
Forward Dividend Yield % | 3.42 | |||||
5-Year Yield-on-Cost % | 2.02 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.7 | |||||
Operating Margin % | 31.69 | |||||
Net Margin % | 19.36 | |||||
FCF Margin % | -27.58 | |||||
ROE % | 38.3 | |||||
ROA % | 15.72 | |||||
ROIC % | 24.73 | |||||
ROC (Joel Greenblatt) % | 66.75 | |||||
ROCE % | 40.41 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 17.13 | |||||
PE Ratio without NRI | 16.1 | |||||
PS Ratio | 3.32 | |||||
PB Ratio | 6.13 | |||||
Price-to-Tangible-Book | 11.35 | |||||
EV-to-EBIT | 10.83 | |||||
EV-to-EBITDA | 9.52 | |||||
EV-to-Revenue | 3.23 | |||||
EV-to-FCF | -11.2 | |||||
Price-to-Graham-Number | 2.85 | |||||
Earnings Yield (Greenblatt) % | 9.23 | |||||
FCF Yield % | -8.31 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Tauns Laboratories Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil 円) | 15,673.099 | ||
EPS (TTM) (円) | 30.349 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 62.93 | ||
14-Day ATR (円) | 22.070711 | ||
20-Day SMA (円) | 481.9 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (円) | 401 - 552 | ||
Shares Outstanding (Mil) | 100 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Tauns Laboratories Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Tauns Laboratories Inc Stock Events
Event | Date | Price(円) | ||
---|---|---|---|---|
No Event Data |
Tauns Laboratories Inc Frequently Asked Questions
What is Tauns Laboratories Inc(TSE:197A)'s stock price today?
When is next earnings date of Tauns Laboratories Inc(TSE:197A)?
Does Tauns Laboratories Inc(TSE:197A) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |